Aclaris Therapeutics, Inc.
Status: Publicly traded
Direct answer
Aclaris Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ACRS.
Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions. The company's operations are divided into two primary divisions: the Therapeutics segment, dedicated to discovering and progressing innovative treatments to address crucial unmet needs in...
Can you invest in Aclaris Therapeutics, Inc.?
Yes. Aclaris Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ACRS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Aclaris Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.